BeyondSpring (BYSI) Tax Provisions (2016 - 2026)
BeyondSpring (BYSI) posted Tax Provisions of $192000.0 for Q1 2026, up 110.22% sequentially from -$1.9 million in Q4 2025, and up 860.0% YoY from $20000.0 in Q1 2025.
BeyondSpring (BYSI) Tax Provisions (2016 - 2026) Analysis & Trends
BeyondSpring has reported Tax Provisions for 9 years, with the latest figure at $192000.0 in Q1 2026.
- Quarterly Tax Provisions rose 860.0% year-over-year to $192000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (up 9.99% YoY) and the FY2025 annual result came in at -$1.8 million, up 1.63% from the prior year.
- Tax Provisions advanced to $192000.0 in Q1 2026 per BYSI's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Tax Provisions peaked at $192000.0 in Q1 2026 and troughed at -$1.9 million in Q4 2025.
- A 3-year average of -$576666.7 and a median of $21000.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions slipped 2.06% in 2025, then jumped 860.0% in 2026.
- Over 3 years, Tax Provisions stood at -$1.8 million in 2024, then slipped by 2.06% to -$1.9 million in 2025, then soared by 110.22% to $192000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $192000.0, -$1.9 million, and $26000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | BeyondSpring | 30.22 Mn | 30.22 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 192,000.00 |
| Dec 31, 2025 | -1.88 Mn |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2021 | -16.16 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Dec 31, 2020 | -13.40 Mn |
| Dec 31, 2019 | -8.47 Mn |
| Dec 31, 2018 | -12.07 Mn |
| Dec 31, 2017 | -33.74 Mn |
| Dec 31, 2016 | -4.39 Mn |